Man Group’s HUMANIGEN, INC. HGEN Stock Holding History

Man Group’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-87,586	Closed	-$16K	–	2321
2022 Q3	$16K	Buy	+87,586	New	+$47.1K	﹤0.01%	1947

Other funds holding HGEN

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Man Group's HGEN Position: Q4 2022 in Review

Man Group sold out of HUMANIGEN, INC. (HGEN) in Q4 2022, closing a stake of 87,586 shares — an estimated $16K sold.

Man Group first reported a position in HGEN in Q3 2022 and held it in 1 quarter. The position peaked at $16K in Q3 2022. 48 funds tracked by Wall St. Rank hold HGEN as of Q4 2022.

Man Group reported no remaining HUMANIGEN, INC. position as of Q4 2022 after selling out during the quarter.
Man Group sold 87,586 HUMANIGEN, INC. shares in Q4 2022, an estimated $16K.
Man Group first reported a position in HUMANIGEN, INC. in Q3 2022 and held it in 1 quarter.
Man Group's HUMANIGEN, INC. position peaked at $16K in Q3 2022.
48 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q4 2022.

Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.